Examination of Edema After Arthroscopic Shoulder Surgery

NCT06014203 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-03-29

No results posted yet for this study

Summary

The investigators's aim is to examine trunk and upper extremity edema after arthroscopic rotator cuff repair and/or labrum repair surgeries. During surgery, the shoulder joint capsule is cut and the joint is entered arthroscopically. During this procedure, approximately 3-6 liters of saline fluid is injected into the joint, depending on the duration of the surgery. The given fluid accumulates out of the joint in relation to the duration of the surgery and the amount of fluid given. In this study, the investigators aim is to examine how much the extra-articular fluid collects under the skin of the upper extremity and trunk, and the change in the amount of fluid 24 hours after surgery. Examination of the amount of subcutaneous fluid may help to better understand the postoperative complications such as edema, carpal tunnel syndrome, compartment syndrome, myolysis, and dyspnea. How much edema the joint and surrounding structures are exposed to and its relationship with the duration of surgery can help to clinicians determine the safe discharge time.

Conditions

  • Edema
  • Arthroscopy
  • Shoulder

Interventions

DIAGNOSTIC_TEST

Edema measurement

Subcutaneous fluid measurements will be made 3 times in total, before the surgery, immediately after the surgery and 24 hours after the surgery. Measurements will be made with the MoistureMeterD Compact local edema measuring device. Points to be measured: 1. Midpoint of the upper trapezius muscle 2. 5 cm distal to anterior acromion 3. 5cm distal to lateral acromion 4. 5cm distal to posterior acromion 5. 3cm medial to the axilla 6. Anterior cubital fossa 7. Carpal tunnel

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Ulunay Kanatlı · Gazi University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-04-30
Completion
2024-05-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06014203 on ClinicalTrials.gov